• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VEGF 通过自分泌环诱导前列腺上皮内瘤样细胞发生上皮-间充质转化(EMT)。

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.

机构信息

Laboratory of Novel Therapeutic Targets, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Avda. Pio XII, 55, 31008 Pamplona, Spain.

出版信息

Exp Cell Res. 2010 Feb 15;316(4):554-67. doi: 10.1016/j.yexcr.2009.11.020. Epub 2009 Dec 16.

DOI:10.1016/j.yexcr.2009.11.020
PMID:20006606
Abstract

Vascular endothelial growth factor (VEGF) is overexpressed during the transition from prostate intraepithelial neoplasia (PIN) to invasive carcinoma. We have mimicked such a process in vitro using the PIN-like C3(1)/Tag-derived Pr-111 cell line, which expresses low levels of VEGF and exhibits very low tumorigenicity in vivo. Elevated expression of VEGF164 in Pr-111 cells led to a significant increase in tumorigenicity, invasiveness, proliferation rates and angiogenesis. Moreover, VEGF164 induced strong changes in cell morphology and cell transcriptome through an autocrine mechanism, with changes in TGF-beta1- and cytoskeleton-related pathways, among others. Further analysis of VEGF-overexpressing Pr-111 cells or following exogenous addition of recombinant VEGF shows acquisition of epithelial-mesenchymal transition (EMT) features, with an increased expression of mesenchymal markers, such as N-cadherin, Snail1, Snail2 (Slug) and vimentin, and a decrease in E-cadherin. Administration of VEGF led to changes in TGF-beta1 signaling, including reduction of Smad7 (TGF-beta inhibitory Smad), increase in TGF-betaR-II, and translocation of phospho-Smad3 to the nucleus. Our results suggest that increased expression of VEGF in malignant cells during the transition from PIN to invasive carcinoma leads to EMT through an autocrine loop, which would promote tumor cell invasion and motility. Therapeutic blockade of VEGF/TGF-beta1 in PIN lesions might impair not only tumor angiogenesis, but also the early dissemination of malignant cells outside the epithelial layer.

摘要

血管内皮生长因子(VEGF)在前列腺上皮内瘤变(PIN)向浸润性癌的转变过程中过度表达。我们在体外使用类似于 PIN 的 C3(1)/Tag 衍生的 Pr-111 细胞系模拟了这样的过程,该细胞系表达低水平的 VEGF,体内致瘤性非常低。Pr-111 细胞中 VEGF164 的高表达导致致瘤性、侵袭性、增殖率和血管生成显著增加。此外,VEGF164 通过自分泌机制导致细胞形态和细胞转录组发生强烈变化,改变 TGF-β1 和细胞骨架相关途径等。进一步分析过表达 VEGF 的 Pr-111 细胞或外源添加重组 VEGF 后,发现获得了上皮间质转化(EMT)特征,间充质标志物如 N-钙粘蛋白、Snail1、Snail2(Slug)和波形蛋白表达增加,E-钙粘蛋白表达减少。VEGF 的给药导致 TGF-β1 信号的改变,包括 Smad7(TGF-β 抑制性 Smad)减少、TGF-βR-II 增加以及磷酸化 Smad3 向核内易位。我们的结果表明,在从 PIN 到浸润性癌的转变过程中,恶性细胞中 VEGF 的表达增加会通过自分泌环导致 EMT,从而促进肿瘤细胞侵袭和迁移。在 PIN 病变中阻断 VEGF/TGF-β1 的治疗可能不仅会损害肿瘤血管生成,还会损害恶性细胞在上皮层外的早期扩散。

相似文献

1
VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.VEGF 通过自分泌环诱导前列腺上皮内瘤样细胞发生上皮-间充质转化(EMT)。
Exp Cell Res. 2010 Feb 15;316(4):554-67. doi: 10.1016/j.yexcr.2009.11.020. Epub 2009 Dec 16.
2
[Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].Smad7对转化生长因子-β1诱导的肺泡上皮细胞向间充质细胞转化的影响
Zhonghua Yi Xue Za Zhi. 2007 Jul 17;87(27):1918-23.
3
Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.血管内皮生长因子受体-1激活介导人胰腺癌细胞上皮-间质转化。
Cancer Res. 2006 Jan 1;66(1):46-51. doi: 10.1158/0008-5472.CAN-05-3086.
4
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).转化生长因子-β1诱导人肺泡上皮细胞向间充质细胞转化(EMT)。
Respir Res. 2005 Jun 9;6(1):56. doi: 10.1186/1465-9921-6-56.
5
TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.TGF-β1 可引起 HaCaT 衍生物的上皮-间充质转化,但仅在良性而非恶性角质形成细胞中诱导 COX-2 表达和迁移。
J Dermatol Sci. 2010 May;58(2):97-104. doi: 10.1016/j.jdermsci.2010.03.002. Epub 2010 Mar 17.
6
Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.TGF-β诱导的上皮-间充质转化的转录组分析揭示细胞外簇蛋白作为治疗性抗体的靶标。
Oncogene. 2010 Feb 11;29(6):831-44. doi: 10.1038/onc.2009.399. Epub 2009 Nov 23.
7
Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.核因子-κB介导的转化生长因子-β诱导的波形蛋白表达是根治性前列腺切除术后生化复发的独立预测指标。
Clin Cancer Res. 2009 May 15;15(10):3557-67. doi: 10.1158/1078-0432.CCR-08-1656.
8
Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.VEGF、FGF2、TGF-β1、2、3及其相关受体在乳腺肿瘤发生过程中的转录失调。
Cancer Lett. 2006 Apr 8;235(1):100-13. doi: 10.1016/j.canlet.2005.04.022. Epub 2005 Jun 9.
9
Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition.铁蛋白重链介导的铁稳态及随后增加的活性氧生成对于上皮-间质转化至关重要。
Cancer Res. 2009 Jul 1;69(13):5340-8. doi: 10.1158/0008-5472.CAN-09-0112. Epub 2009 Jun 16.
10
Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.基底细胞的局灶性变性及由此产生的自身免疫反应:前列腺肿瘤进展和侵袭的新机制。
Med Hypotheses. 2008;70(2):387-408. doi: 10.1016/j.mehy.2007.05.015. Epub 2007 Jul 20.

引用本文的文献

1
Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease.基质金属蛋白酶驱动的上皮-间质转化:对健康与疾病的影响
J Transl Med. 2025 Apr 11;23(1):436. doi: 10.1186/s12967-025-06447-w.
2
Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.缺氧诱导因子-1α 介导巴雷特食管患者反流诱导的上皮-间充质可塑性。
Gut. 2024 Jul 11;73(8):1269-1279. doi: 10.1136/gutjnl-2023-331467.
3
Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages.
基于表观遗传学的联合疗法和脂质体共递送通过使肿瘤相关巨噬细胞重新极化克服奥希替尼耐药的非小细胞肺癌。
Acta Pharmacol Sin. 2024 Apr;45(4):867-878. doi: 10.1038/s41401-023-01205-4. Epub 2023 Dec 19.
4
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of against COVID-19/LUSC.网络药理学和生物信息学分析鉴定 治疗 COVID-19/LUSC 的潜在治疗靶点。
Front Endocrinol (Lausanne). 2023 Jun 6;14:1187882. doi: 10.3389/fendo.2023.1187882. eCollection 2023.
5
The role of infected epithelial cells in -associated fibrosis.上皮细胞感染在纤维化中的作用。
Front Cell Infect Microbiol. 2023 May 17;13:1208302. doi: 10.3389/fcimb.2023.1208302. eCollection 2023.
6
The Role of Epithelial Mesenchymal Transition (EMT) in Pathogenesis of Cardiotoxicity: Diagnostic & Prognostic Approach.上皮间质转化(EMT)在心脏毒性发病机制中的作用:诊断和预后方法。
Mol Biotechnol. 2023 Sep;65(9):1403-1413. doi: 10.1007/s12033-023-00697-z. Epub 2023 Feb 27.
7
The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping.基于分子亚型的lncRNAs在上皮-间质转化与早期结肠腺癌肿瘤微环境相互作用中的机制
Front Genet. 2022 Nov 16;13:997739. doi: 10.3389/fgene.2022.997739. eCollection 2022.
8
Ishophloroglucin A Ameliorates VEGF-Induced Epithelial-Mesenchymal Transition via VEGFR2 Pathway Inhibition in Microgravity-Stimulated Human Retinal Pigment Epithelial Cells.异荭草素A通过抑制VEGFR2信号通路改善微重力刺激下人视网膜色素上皮细胞中VEGF诱导的上皮-间质转化
Antioxidants (Basel). 2022 Nov 8;11(11):2212. doi: 10.3390/antiox11112212.
9
Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor.小檗碱作为一种多激酶抑制剂抑制胆管癌细胞的进展。
Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3379-3386. doi: 10.31557/APJCP.2022.23.10.3379.
10
Olive leaf extract inhibits metastatic melanoma spread through suppression of epithelial to mesenchymal transition.橄榄叶提取物通过抑制上皮间质转化抑制转移性黑色素瘤的扩散。
Phytother Res. 2022 Oct;36(10):4002-4013. doi: 10.1002/ptr.7587. Epub 2022 Aug 10.